Glycogen synthase kinase-3 in the etiology and treatment of mood disorders

by Richard Scott Jope
Published 2011-08-01

Glycogen synthase kinase-3: A promising therapeutic target for Fragile X Syndrome

by Marjelo M. Mines, Richard Scott Jope
Published 2011-11-01

Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3

by Marjelo A. Mines, Eleonore Beurel, Richard S. Jope
Published 2011-01-01

Astrocytes modulate the polarization of CD4+ T cells to Th1 cells.

by Eléonore Beurel, Laurie E Harrington, William Buchser, Vance Lemmon, Richard S Jope
Published 2014-01-01

GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.

by Marjelo A Mines, Christopher J Yuskaitis, Margaret K King, Eleonore Beurel, Richard S Jope
Published 2010-03-01

Neurological functions of the masterswitch protein kinase – GSK-3

by Oksana eKaidanovich-Beilin, Jean-Martin eBeaulieu, Richard Scott Jope, James Robert Woodgett, James Robert Woodgett
Published 2012-04-01

Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3

by Marta ePardo, Margaret K. King, EMMA ePEREZ-COSTAS, Miguel eMelendez-Ferro, Ana eMartinez, Eleonore eBeurel, Richard Scott Jope
Published 2015-03-01